USD 532.14
(2.67%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | -82.1 Million USD | -217.96% |
2022 | 69.6 Million USD | -20.0% |
2021 | 87 Million USD | 50.0% |
2020 | 58 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 100.0% |
2009 | -53.34 Million USD | -43.51% |
2008 | -37.17 Million USD | -89.64% |
2007 | -19.6 Million USD | 0.0% |
2006 | - USD | 100.0% |
2005 | -35.95 Million USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 695 Thousand USD | -62.19% |
2002 | 1.83 Million USD | 138.39% |
2001 | 771 Thousand USD | -58.57% |
2000 | 1.86 Million USD | -26.18% |
1999 | 2.52 Million USD | 3.4% |
1998 | 2.43 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q3 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 FY | -82.1 Million USD | -217.96% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | -82.1 Million USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | -100.0% |
2022 FY | 69.6 Million USD | -20.0% |
2022 Q4 | 69.6 Million USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | 87 Million USD | 0.0% |
2021 FY | 87 Million USD | 50.0% |
2021 Q1 | - USD | -100.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 58 Million USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q4 | 58 Million USD | 0.0% |
2019 Q4 | - USD | -100.0% |
2019 Q2 | 69.6 Million USD | -2.38% |
2019 Q3 | 72.2 Million USD | 3.74% |
2019 Q1 | 71.3 Million USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 100.0% |
2010 FY | - USD | 100.0% |
2009 FY | -53.34 Million USD | -43.51% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | -53.34 Million USD | 0.0% |
2009 Q1 | - USD | 100.0% |
2008 Q3 | -34.45 Million USD | -24.19% |
2008 Q1 | -23.34 Million USD | -19.09% |
2008 Q2 | -27.74 Million USD | -18.87% |
2008 Q4 | -37.17 Million USD | -7.87% |
2008 FY | -37.17 Million USD | -89.64% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | -19.6 Million USD | 0.0% |
2007 FY | -19.6 Million USD | 0.0% |
2006 Q1 | -15.71 Million USD | 56.3% |
2006 FY | - USD | 100.0% |
2006 Q4 | - USD | 100.0% |
2006 Q3 | -16.16 Million USD | -0.57% |
2006 Q2 | -16.07 Million USD | -2.29% |
2005 FY | -35.95 Million USD | 0.0% |
2005 Q4 | -35.95 Million USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2004 Q2 | 230 Thousand USD | -47.13% |
2004 Q3 | 52 Thousand USD | -77.39% |
2004 Q1 | 435 Thousand USD | -37.41% |
2004 Q4 | - USD | -100.0% |
2004 FY | - USD | -100.0% |
2003 FY | 695 Thousand USD | -62.19% |
2003 Q4 | 695 Thousand USD | -26.84% |
2003 Q3 | 950 Thousand USD | -23.08% |
2003 Q2 | 1.23 Million USD | -19.33% |
2003 Q1 | 1.53 Million USD | -16.7% |
2002 FY | 1.83 Million USD | 138.39% |
2002 Q3 | 1.79 Million USD | 84.55% |
2002 Q2 | 971 Thousand USD | -24.26% |
2002 Q1 | 1.28 Million USD | 66.28% |
2002 Q4 | 1.83 Million USD | 2.57% |
2001 Q2 | 772 Thousand USD | -47.59% |
2001 Q1 | 1.47 Million USD | -20.85% |
2001 FY | 771 Thousand USD | -58.57% |
2001 Q3 | 963 Thousand USD | 24.74% |
2001 Q4 | 771 Thousand USD | -19.94% |
2000 Q1 | 2.47 Million USD | 0.0% |
2000 FY | 1.86 Million USD | -26.18% |
2000 Q3 | 1.24 Million USD | -39.11% |
2000 Q2 | 2.03 Million USD | -17.52% |
2000 Q4 | 1.86 Million USD | 49.96% |
1999 FY | 2.52 Million USD | 3.4% |
1998 FY | 2.43 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Phreesia, Inc. | 2.04 Million USD | 4106.833% |
Accuray Incorporated | 164.4 Million USD | 149.939% |
Align Technology, Inc. | 96.96 Million USD | 184.667% |
Elevance Health Inc. | 23.24 Billion USD | 100.353% |
AxoGen, Inc. | 46.6 Million USD | 276.169% |
Boston Scientific Corporation | 8.56 Billion USD | 100.958% |
CVS Health Corporation | 74.67 Billion USD | 100.11% |
Cardinal Health, Inc. | 4.58 Billion USD | 101.791% |
Centene Corporation | 17.69 Billion USD | 100.464% |
DaVita Inc. | 8.05 Billion USD | 101.02% |
HCA Healthcare, Inc. | 36.62 Billion USD | 100.224% |
Hologic, Inc. | 2.49 Billion USD | 103.288% |
Humana Inc. | 10.21 Billion USD | 100.804% |
IDEXX Laboratories, Inc. | 622.88 Million USD | 113.181% |
Laboratory Corporation of America Holdings | 4.05 Billion USD | 102.025% |
Masimo Corporation | 871.7 Million USD | 109.418% |
McKesson Corporation | 5.45 Billion USD | 101.506% |
Patterson Companies, Inc. | 328.91 Million USD | 124.961% |
Quest Diagnostics Incorporated | 4.41 Billion USD | 101.862% |
ResMed Inc. | 697.31 Million USD | 111.774% |
Henry Schein, Inc. | 1.93 Billion USD | 104.247% |
Teladoc Health, Inc. | 1.58 Billion USD | 105.191% |
Universal Health Services, Inc. | 4.71 Billion USD | 101.741% |
Veeva Systems Inc. | 46.44 Million USD | 276.783% |
Baxter International Inc. | 11.06 Billion USD | 100.742% |
Becton, Dickinson and Company | 14.73 Billion USD | 100.557% |
Danaher Corporation | 17.66 Billion USD | 100.465% |
Stryker Corporation | 10.9 Billion USD | 100.753% |
Medtronic plc | 23.87 Billion USD | 100.344% |